Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Vytorin Versus Standard Treatment of Other Statins in Moderate, Moderately High and High Risk Participants (MK-0653A-406) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Vytorin vs standard statin therapy for dyslipidemia was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia

Drugs mentioned

• Vytorin (ezetimibe/simvastatin)

Snippet

Sponsor: Organon and Co | Conditions: Dyslipidemia | Phase 4 | Status: WITHDRAWN